skip to main content

S. 484 (110th): Enhancing Drug Safety and Innovation Act of 2007

A bill to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, and for other purposes.

The bill’s titles are written by its sponsor.

Michael Enzi

Sponsor. Senator for Wyoming. Republican.

Read Text »
Last Updated: Feb 1, 2007
Length: 115 pages
Introduced:

Feb 1, 2007
110th Congress, 2007–2009

Status:
Died in a previous Congress

This bill was introduced on February 1, 2007, in a previous session of Congress, but was not enacted. Provisions of this bill were incorporated into other bills.

Provisions of this bill also appear in:

H.R. 3580: Food and Drug Administration Amendments Act of 2007
Enacted — Signed by the President on Sep 27, 2007. (compare text)

History

Feb 1, 2007
 
Introduced

Bills and resolutions are referred to committees which debate the bill before possibly sending it on to the whole chamber.

S. 484 (110th) was a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

This bill was introduced in the 110th Congress, which met from Jan 4, 2007 to Jan 3, 2009. Legislation not enacted by the end of a Congress is cleared from the books.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“S. 484 — 110th Congress: Enhancing Drug Safety and Innovation Act of 2007.” www.GovTrack.us. 2007. December 17, 2017 <https://www.govtrack.us/congress/bills/110/s484>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.